Overweight Clinical Trial
Official title:
Effects of Journaling on Weight Loss
This is a randomized controlled trial with enhanced usual care treatment control. The aim is to determine the effects of journaling and use of resource website on weight loss. There will be two groups of 55 participants each. The intervention condition will be asked to record daily weight, physical activity steps taken and pre-portioned food items and to complete two daily journaling activities. Participants will also receive weekly tracing data, a weekly blog from the principal investigator and have access to a weight control website. The control group will not have access to the tracking, journaling or website for three months. Investigators hypothesize that a website paired with tracking and journaling will be more effective in helping participants lose weight.
Status | Completed |
Enrollment | 100 |
Est. completion date | January 2013 |
Est. primary completion date | January 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 21 Years to 65 Years |
Eligibility |
Inclusion Criteria: - 21 to 65 years old - Body mass index between 27 and 45 - E-mail and Internet access - Able to read, write, and understand English Exclusion Criteria: - Weight loss of more than 5% of current body weight in previous 6 months - Participated in weight loss research in previous 6 months - Current use of weight loss medication or program - History of or scheduled weight loss surgery - Heart, liver, or kidney failure - Been told by doctor of heart trouble - Frequent pains in heart and chest - Often feel faint or have spells of severe dizziness - Bone or joint problem that has been or might be aggravated by exercise - Physical reason for not following activity program - History of sever cognitive impairment or major psychiatric illness - Pregnant in previous 6 months, currently or planning to become pregnant in next 3 months - Moving in next 6 months |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Penn State Milton S. Hershey Medical Center | Hershey | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
Milton S. Hershey Medical Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Sociodemographics and tobacco use | Age, gender, race, ethnicity, education, smoking status and other demographics will be measured by self-report | 3 months | No |
Other | Three-factor Eating Questionnaire | Questionnaire asks participants about how their dietary restraint in specific circumstances | 3 months | No |
Other | Motivation | Questionnaire asks participants to gauge their motivation to lose weight. | 3 months | No |
Other | Weight Loss Habits | Questionnaire asks participants how often they use specific habits to lose weight | 3 months | No |
Other | Blood Pressure Medication | Blood pressure medication names, doses and frequency measured by self-report | 3 months | No |
Other | International Physical Activity Questionnaire | Questionnaire asks participants to estimate the frequency and duration of specific physical activities | 3 months | No |
Other | Satisfaction Survey | Questionnaire asks participants about their satisfaction with specific aspects of the study | 3 months | No |
Primary | Weight | Weight will be measured by study staff using a Tanita BWB 800S Digital Scale. | 3 months | No |
Secondary | Blood Pressure | Blood pressure will be measured by study staff using an automatic blood pressure monitor. | 3 months | No |
Secondary | Height | Height will be measured using a portable stadiometer. | 3 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Terminated |
NCT03299881 -
Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss
|
N/A | |
Completed |
NCT02805478 -
Fat-Associated Cardiovascular Organ Dysfunction
|
||
Active, not recruiting |
NCT02558920 -
Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
|
||
Completed |
NCT03759743 -
Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject
|
N/A | |
Completed |
NCT03610958 -
Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss.
|
N/A | |
Completed |
NCT03678766 -
CHARGE: Controlling Hunger and ReGulating Eating
|
N/A | |
Completed |
NCT04430465 -
Effects of Wholegrains on Children's Health (KORN)
|
N/A | |
Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
Completed |
NCT05376865 -
Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers
|
N/A | |
Completed |
NCT03625427 -
Effect of Palmitoleic Acid on C-reactive Protein
|
N/A | |
Active, not recruiting |
NCT03435445 -
Online Platform for Healthy Weight Loss (POEmaS)
|
N/A | |
Enrolling by invitation |
NCT05576116 -
Combined Bariatric Surgery and Pancreas After Kidney Transplantation for Type II Diabetics
|
N/A | |
Recruiting |
NCT05249465 -
Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention
|
N/A | |
Active, not recruiting |
NCT06023095 -
A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
|
Phase 1 | |
Completed |
NCT03648892 -
Brain Dopamine Function in Human Obesity
|
Early Phase 1 | |
Not yet recruiting |
NCT05751993 -
Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive Interventions
|
N/A | |
Recruiting |
NCT02887950 -
Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause
|
N/A | |
Terminated |
NCT02743598 -
Liraglutide for HIV-associated Neurocognitive Disorder
|
Phase 4 | |
Completed |
NCT02899390 -
Diabetes Prevention Program in Adults of the Yaqui Tribe of Hermosillo, Sonora at Risk of Diabetes
|
N/A |